Raphaël Ortiz

Corporate Officer/Principal en TELIX PHARMACEUTICALS LIMITED .

50 años

Consumer Services

Health Technology

Perfil

Raphaël Ortiz is currently the Chief Executive Officer-Telix International at Telix Pharmaceuticals Ltd. He is also a Co-Managing Director at Rhine Pharma GmbH.
Previously, he worked as the Head-Asia Pacific Cluster at Advanced Accelerator Applications SA. Mr. Ortiz holds a graduate degree from the University of Seville and the University of Reims Champagne-Ardenne.
He also has an MBA from Kenan-Flagler Business School.

Cargos activos de Raphaël Ortiz

Empresas	Cargo	Inicio
TELIX PHARMACEUTICALS LIMITED	Corporate Officer/Principal	01/01/2022

Todos los cargos activos de Raphaël Ortiz

Antiguos cargos conocidos de Raphaël Ortiz.

Empresas	Cargo	Fin
ADVANCED ACCELERATOR APPLICATION SA(ADR)	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Raphaël Ortiz.

Formación de Raphaël Ortiz.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Raphaël Ortiz.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
University of Seville University of Seville Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Reims Champagne-Ardenne University of Reims Champagne-Ardenne Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Advanced Accelerator Applications SA Advanced Accelerator Applications SA Pharmaceuticals: MajorHealth Technology Develops and produces nuclear medicine and radioligand therapies	Health Technology
Kenan-Flagler Business School Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Telix Pharmaceuticals Ltd. Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals	Health Technology